{"mainPropery":{"diseaseId":2520,"diseaseName":"Glycogen storage disease type 4","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/2520/glycogen-storage-disease-type-4","synonyms":["GSD 4","Andersen disease","Brancher deficiency","Amylopectinosis","Glycogen branching enzyme deficiency","Cirrhosis, familial, with deposition of abnormal glycogen","Glycogenosis 4","Glycogen storage disease type IV","GSD IV"],"synonyms-with-source":[{"name":"GSD 4"},{"name":"Andersen disease"},{"name":"Brancher deficiency"},{"name":"Amylopectinosis"},{"name":"Glycogen branching enzyme deficiency"},{"name":"Cirrhosis, familial, with deposition of abnormal glycogen"},{"name":"Glycogenosis 4"},{"name":"Glycogen storage disease type IV"},{"name":"GSD IV"}],"identifiers":[{"identifierType":"OMIM","identifierId":"232500"},{"identifierType":"ORPHANET","identifierId":"367"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases"},{"diseaseTypeId":4,"diseaseTypeName":"Heart Diseases"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases"}],"organizations":[{"resourceID":138,"resourceName":"Metabolic Support UK","abbreviation":"","address1":"5 Hilliards Court","address2":"Sandpiper Way","address3":"Chester Business Park","address4":"","address5":"","city":"Chester","state":"","zip":"CH4 9QP","country":"United Kingdom","phone":"0845 241 2173","tty":"","tollFree":"0800 652 3181 ","fax":"","email":"https://www.metabolicsupportuk.org/contact-us","url":"https://www.metabolicsupportuk.org","freeText":""},{"resourceID":302,"resourceName":"Association for Glycogen Storage Disease UK","abbreviation":"AGSD-UK","address1":"PO Box 1232","address2":"Bristol","address3":"BS48 9DD","address4":"","address5":"","city":"","state":"","zip":"","country":"United Kingdom","phone":"0300 123 2790","tty":"","tollFree":"","fax":"","email":"https://agsd.org.uk/contact/message-us2/","url":"http://www.agsd.org.uk/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/232500' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='https://www.ncbi.nlm.nih.gov/pubmed/?term=glycogen-storage-disease-type-4' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Glycogen storage disease type 4. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Glycogen+storage+disease+type+4%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Glycogen storage disease type 4. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/gene/GBE1' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Glycogen storage disease type 4. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C0017923' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://rarediseases.org/rare-diseases/andersen-disease-gsd-iv/' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/119690-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=367' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='https://www.ncbi.nlm.nih.gov/books/NBK115333/' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:232500' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":5218,"questionText":"What is glycogen storage disease type 4?","answerText":"<strong>Glycogen storage disease type 4</strong> (GSD 4) is&nbsp;part of a group of&nbsp;disorders which lead to abnormal accumulation of glycogen (a storage form of glucose)&nbsp;in various parts of the body. Symptoms of GSD 4&nbsp;usually begin in infancy and typically include&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000991.htm\" target=_blank>failure to thrive</a>; enlarged liver and spleen (hepatosplenomegaly); and in many cases, progressive <a href=\"http://www.nlm.nih.gov/medlineplus/cirrhosis.html\" target=_blank>liver cirrhosis</a> and liver failure. In rare cases individuals may have a form with&nbsp;non-progressive liver disease, or a severe neuromuscular form. GSD 4 is caused by&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" target=_blank>mutations</a> in the <a href=\"http://ghr.nlm.nih.gov/gene/GBE1\" target=_blank><em>GBE1</em></a> gene and is&nbsp;inherited&nbsp;in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=_blank>autosomal recessive</a> manner. Treatment typically focuses on the specific symptoms that are present in each individual.[4270]","dateModified":"2012-12-23T20:58:00"},"basicQuestions":[{"questionId":5236,"questionText":"What are the signs and symptoms of glycogen storage disease type 4?","answerText":"The signs and symptoms of glycogen storage disease type 4 (GSD 4) can vary greatly between affected individuals, and several forms of GSD 4 have been described.&nbsp;Most affected&nbsp;individuals have a \"classic\" form characterized by&nbsp;progressive <a href=\"http://www.nlm.nih.gov/medlineplus/cirrhosis.html\" target=_blank>cirrhosis</a> of the liver, eventually leading to liver failure. In these individuals, signs and symptoms typically begin in infancy and include failure to grow and gain weight appropriately (failure to thrive); enlargement of the liver and spleen (hepatosplenomegaly); abnormal fluid&nbsp;build-up in the abdomen (ascites); and enlargement of veins in the wall of the esophagus (esophageal varices) which may rupture and cause coughing up of blood. <a href=\"http://www.liverfoundation.org/abouttheliver/info/progression/\" target=_blank>Progressive liver disease</a> in&nbsp;affected children can lead to the need for a liver transplant or life-threatening complications by approximately 5 years of age. There have been some reports of affected&nbsp;individuals&nbsp;having nonprogressive liver disease; very mildly affected individuals may not&nbsp;show signs and symptoms of the disease.[4270]<br><br>There have also been reports of neuromuscular forms of GSD 4, most of which become apparent in late childhood. These may be characterized by skeletal muscle or heart muscle disease (myopathy or cardiomyopathy)&nbsp;caused by the accumulation of glycogen in the muscle tissue. Signs and symptoms in these cases may include muscle weakness or fatigue, exercise intolerance, and&nbsp;muscle wasting (atrophy). Complications with these forms may include <a href=\"http://www.nlm.nih.gov/medlineplus/heartfailure.html\" target=_blank>heart failure</a>.<br><br>A more severe neuromuscular form that is apparent at birth has also been reported; this form may be characterized by generalized edema (swelling cause by fluid); decreased muscle tone (hypotonia); muscle weakness and wasting; joints having fixed positions (contractures); and neurologic involvement, which can cause&nbsp;life-threatening complications early in life.[4270]","dateModified":"2011-09-08T11:16:00","resourceClassificationName":"Symptoms","references":[{"referenceId":4270,"authors":"Marsden D","articleTitle":"Andersen Disease (GSD IV)","bookWebsiteJournalTitle":"NORD","date":"2012","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/394/viewAbstract","dateAccessed":"2012-12-23T00:00:00"}]},{"questionId":5238,"questionText":"What causes glycogen storage disease type 4?","answerText":"Glycogen storage disease type 4 (GSD 4) is caused by&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" target=_blank>mutations</a> in the <a href=\"http://ghr.nlm.nih.gov/gene/GBE1\" target=_blank><em>GBE1</em></a> gene. The <em>GBE1</em> gene normally provides instructions for making the glycogen branching enzyme. This enzyme is necessary for making glycogen,&nbsp;a major source of stored energy in the body. Glycogen&nbsp;is formed by assembling many molecules of glucose. The glycogen branching enzyme is involved in the formation of \"branches\" of glucose chains, which help to make&nbsp;glycogen more compact for storage&nbsp;and allows it to break down more easily when it is needed for energy. The GBE1 gene mutations that cause GSD 4 lead to a decrease in the amount or functionality of the glycogen branching enzyme. Glycogen is then not formed properly, and substances called polyglucosan bodies build up in cells throughout the body, causing the signs and symptoms of the condition.[4293]","dateModified":"2012-12-23T20:59:00","resourceClassificationName":"Cause","references":[{"referenceId":4293,"authors":"","articleTitle":"GBE1","bookWebsiteJournalTitle":"Genetics Home Reference","date":"November 2009","url":"http://ghr.nlm.nih.gov/gene/GBE1","dateAccessed":"2012-12-23T00:00:00"}]},{"questionId":5237,"questionText":"How is glycogen storage disease type 4 inherited?","answerText":"Glycogen storage disease type 4 is inherited in an autosomal recessive manner. This means that an individual must have 2 abnormal copies of the <a href=\"http://ghr.nlm.nih.gov/gene/GBE1\" target=_blank><em>GBE1</em></a> gene to be affected (one abnormal&nbsp;copy inherited from each parent). Individuals with one abnormal copy of the GBE1 gene, such as the&nbsp;parents of an affected individual, are referred to as carriers. Carriers typically do not have signs or symptoms of an autosomal recessive condition. When two carriers of an autosomal recessive condition are having children, each of their children has a 25% (1 in 4) risk to be affected, a 50% (1 in 2)&nbsp;risk to be a carrier like each parent, and a 25% chance to not be a carrier and not be affected.","dateModified":"2012-12-23T21:00:00","resourceClassificationName":"Inheritance","references":[]},{"questionId":5239,"questionText":"How might glycogen storage disease type 4 be treated?","answerText":"Management of glycogen storage disease type 4 typically focuses on the signs and symptoms that are present in each individual. Studies have show that in some cases, strict dietary therapy&nbsp;can help to&nbsp;maintain normal levels of glucose in the blood, reduce liver size, reduce symptoms, and allow for improved growth and development.&nbsp;Growing evidence indicates that a high-protein diet may improve muscle function in individuals with weakness or exercise intolerance and slow disease progression. Supportive care is typically needed for complications such as liver failure, heart failure, and neurologic dysfunction. Liver transplantation may be necessary for individuals with&nbsp;progressive&nbsp;liver disease. Individuals with cardiomyopathy may require the use of certain medications.[4294][4270]","dateModified":"2011-09-08T12:03:00","resourceClassificationName":"Treatment","references":[{"referenceId":4270,"authors":"Marsden D","articleTitle":"Andersen Disease (GSD IV)","bookWebsiteJournalTitle":"NORD","date":"2012","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/394/viewAbstract","dateAccessed":"2012-12-23T00:00:00"},{"referenceId":4294,"authors":"Wayne E Anderson","articleTitle":"Glycogen Storage Disease, Type IV Treatment & Management","bookWebsiteJournalTitle":"eMedicine","date":"November 12, 2009","url":"http://emedicine.medscape.com/article/119690-treatment#showall","dateAccessed":"2011-09-08T00:00:00"}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":12259,"relatedDiseaseName":"Glycogen storage disease","relation":"Parent","isRare":false,"hasGardPage":false}],"gardCases":[{"caseId":37516,"abbreviatedInquiry":"I was wondering if there is any way for parents that have had a baby with glycogen storage disease type 4 (GSD4) to have a child without this condition. For example, is amniocentesis available or can this be done through in vitro fertilization (IVF)?","caseQuestions":[{"questionId":5238,"questionText":"What causes glycogen storage disease type 4?","answerText":"Glycogen storage disease type 4 (GSD 4) is caused by&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" target=_blank>mutations</a> in the <a href=\"http://ghr.nlm.nih.gov/gene/GBE1\" target=_blank><em>GBE1</em></a> gene. The <em>GBE1</em> gene normally provides instructions for making the glycogen branching enzyme. This enzyme is necessary for making glycogen,&nbsp;a major source of stored energy in the body. Glycogen&nbsp;is formed by assembling many molecules of glucose. The glycogen branching enzyme is involved in the formation of \"branches\" of glucose chains, which help to make&nbsp;glycogen more compact for storage&nbsp;and allows it to break down more easily when it is needed for energy. The GBE1 gene mutations that cause GSD 4 lead to a decrease in the amount or functionality of the glycogen branching enzyme. Glycogen is then not formed properly, and substances called polyglucosan bodies build up in cells throughout the body, causing the signs and symptoms of the condition.[4293]","dateModified":"2012-12-23T20:59:00","resourceClassificationName":"Cause","references":[{"referenceId":4293,"authors":"","articleTitle":"GBE1","bookWebsiteJournalTitle":"Genetics Home Reference","date":"November 2009","url":"http://ghr.nlm.nih.gov/gene/GBE1","dateAccessed":"2012-12-23T00:00:00"}]},{"questionId":5237,"questionText":"How is glycogen storage disease type 4 inherited?","answerText":"Glycogen storage disease type 4 is inherited in an autosomal recessive manner. This means that an individual must have 2 abnormal copies of the <a href=\"http://ghr.nlm.nih.gov/gene/GBE1\" target=_blank><em>GBE1</em></a> gene to be affected (one abnormal&nbsp;copy inherited from each parent). Individuals with one abnormal copy of the GBE1 gene, such as the&nbsp;parents of an affected individual, are referred to as carriers. Carriers typically do not have signs or symptoms of an autosomal recessive condition. When two carriers of an autosomal recessive condition are having children, each of their children has a 25% (1 in 4) risk to be affected, a 50% (1 in 2)&nbsp;risk to be a carrier like each parent, and a 25% chance to not be a carrier and not be affected.","dateModified":"2012-12-23T21:00:00","resourceClassificationName":"Inheritance","references":[]},{"questionId":6622,"questionText":"What are the&nbsp;chances for a couple who has had a baby with glycogen storage disease type 4 to have a baby that is not affected?","answerText":"At conception, each sibling of an affected individual has a 25% chance of being affected, a 50% chance of being a carrier&nbsp;(without symptoms), and a 25% chance of being unaffected and not a carrier. That means that in each future pregnancy, there is a&nbsp;1 in 4 (25%) chance that another baby with&nbsp;glycogen storage disease type 4&nbsp;will be conceived.","dateModified":"2012-12-23T21:02:00","references":[]},{"questionId":6623,"questionText":"Is prenatal diagnosis available for pregnancies at-risk for glycogen storage disease type 4?","answerText":"Prenatal diagnosis for pregnancies at increased risk for glycogen storage disease type 4&nbsp;is possible by analysis of DNA extracted from fetal cells obtained by <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003921.htm\" target=_blank>amniocentesis</a> usually performed at approximately 15 to 18 weeks’ gestation or <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003406.htm\" target=_blank>chorionic villus sampling</a> (CVS) at approximately ten to 12 weeks’ gestation. Both disease-causing alleles of an affected family member must be identified before prenatal testing can be performed.","dateModified":"2012-12-23T21:06:00","references":[]},{"questionId":6624,"questionText":"Are there procedures that can detect glycogen storage disease type 4 at the in vitro fertilization (IVF) level?","answerText":"<a href=\"http://www.dnapolicy.org/policy.issue.php?action=detail&amp;issuebrief_id=7\" target=_blank>Preimplantation genetic diagnosis</a> (PGD), a procedure which can be used in conjunction with <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/007279.htm\" target=_blank>in vitro fertilization</a> (IVF),&nbsp;may be available for families in which the disease-causing mutations have been identified. <a href=\"http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/clinical_lab_service_id/3036?db=genetests\" target=_blank>Click here</a> to access a listing of laboratories which offer PGD.","dateModified":"2012-12-23T21:08:00","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":7160,"phenoTypeName":"Abnormal cardiomyocyte morphology","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":12923,"phenoTypeName":"Abnormal muscle glycogen content","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11638,"phenoTypeName":"Abnormal neuron branching","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":4197,"phenoTypeName":"Generalized abnormality of skin","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8976,"phenoTypeName":"Dilated cardiomyopathy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4319,"phenoTypeName":"Elevated hepatic transaminase","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4081,"phenoTypeName":"Failure to thrive","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9384,"phenoTypeName":"Generalized hypotonia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14531,"phenoTypeName":"Hypoalbuminemia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8729,"phenoTypeName":"Motor delay","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14500,"phenoTypeName":"Myopathy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4096,"phenoTypeName":"Ascites","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5689,"phenoTypeName":"Cirrhosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4779,"phenoTypeName":"Congestive heart failure","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13431,"phenoTypeName":"Esophageal varix","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13091,"phenoTypeName":"Fetal akinesia sequence","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5672,"phenoTypeName":"Flexion contracture","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5685,"phenoTypeName":"Hepatic failure","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8125,"phenoTypeName":"Hepatosplenomegaly","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5032,"phenoTypeName":"Nonimmune hydrops fetalis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4738,"phenoTypeName":"Polyhydramnios","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5701,"phenoTypeName":"Portal hypertension","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":12803,"phenoTypeName":"Prolonged partial thromboplastin time","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":1361,"phenoTypeName":"Prolonged prothrombin time","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13728,"phenoTypeName":"Respiratory distress","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13725,"phenoTypeName":"Respiratory insufficiency","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":12149,"phenoTypeName":"Severe muscular hypotonia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14505,"phenoTypeName":"Skeletal muscle atrophy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":7899,"phenoTypeName":"Arthrogryposis multiplex congenita","percentRanges":"-"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":4782,"phenoTypeName":"Cardiomyopathy","percentRanges":"-"},{"phenoTypeId":4736,"phenoTypeName":"Decreased fetal movement","percentRanges":"-"},{"phenoTypeId":8259,"phenoTypeName":"Edema","percentRanges":"-"},{"phenoTypeId":3910,"phenoTypeName":"Hydrops fetalis","percentRanges":"-"},{"phenoTypeId":9419,"phenoTypeName":"Muscle weakness","percentRanges":"-"},{"phenoTypeId":8716,"phenoTypeName":"Muscular hypotonia","percentRanges":"-"},{"phenoTypeId":9404,"phenoTypeName":"Reduced tendon reflexes","percentRanges":"-"},{"phenoTypeId":15045,"phenoTypeName":"Tubulointerstitial fibrosis","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Glycogen_storage_disease_type_4"}